Archive | Of Interest

The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: A nationwide population-based matched cohort study in Korea

Source: MDLinx, July 2019 Researchers conducted this retrospective, matched cohort study to quantify the incidence of melanoma and nonmelanoma skin cancer (NMSC) in Korean vitiligo patients and compare it with their matched non-vitiligo controls. The study sample consisted of 131,245 incident vitiligo cases and 2,624,900 age and sex-matched (1:20) controls at index date, who were […]

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Protein linked to aggressive skin cancer

Source: ScienceDaily, July 2019 Almost 300,000 people worldwide develop malignant melanoma each year. The disease is the most serious form of skin cancer and the number of cases reported annually is increasing, making skin cancer one of Sweden’s most common forms of cancer. A research team at Lund University in Sweden has studied a protein […]

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Calculated tumor area provides independent prognostic value for patients with melanoma

Source: Healio, July 2019 A new two-dimensional feature called calculated tumor area appears to have effective independent prognostic value in patients with melanoma, according to a retrospective cohort study published in JAMA Dermatology. Researchers said that studying this feature further should become a priority. “We have now devised a newer feature, the calculated tumor area (CTA), […]

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

With Biomarker Expansion, Combinations and Personalized Medicine Continue to Rise

Source: Targeted Oncology, July 2019 Even as targeted therapies continue to meet regulatory approvals, more and more biomarkers are being used to define cancer more precisely across tumor types. Biomarker expansion has enjoyed a boom since 2006, with patient incidence of positive biomarkers reaching up to 50% in non–small cell lung cancer (NSCLC) and melanoma […]

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest